Lactobacillus plantarum ( DrugBank: Lactobacillus plantarum )

---

3 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	4
97	Ulcerative colitis	1
156	Rett syndrome	1

6. Parkinson disease

---

Clinical trials : 2,298 /  Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04722198 (ClinicalTrials.gov)	October 27, 2020	15/1/2021	Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study	Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study	Early Onset Parkinson Disease	Dietary Supplement: PS128	Professor Lu Neurological Clinic	NULL	Recruiting	20 Years	80 Years	All	20	N/A	Taiwan
2	NCT04722211 (ClinicalTrials.gov)	July 6, 2020	15/1/2021	Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease.	Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease.	Parkinson Disease	Dietary Supplement: PS128;Dietary Supplement: placebo	Professor Lu Neurological Clinic	NULL	Recruiting	45 Years	80 Years	All	120	N/A	Taiwan
3	NCT04389762 (ClinicalTrials.gov)	June 4, 2019	30/4/2020	PS128 May Improve Off Duration on Parkinson's Disease	Lactobacillus Plantarum PS128 May Improve Off Duration in Parkinson's Disease: a Pilot Study	Parkinson Disease	Dietary Supplement: daily ingestion of Lactobacillus plantarum PS128	Professor Lu Neurological Clinic	NULL	Completed	40 Years	80 Years	All	60	N/A	Taiwan
4	NCT03566589 (ClinicalTrials.gov)	July 2, 2018	12/6/2018	Effects of PS128 on Parkinsonian Symptoms	Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease: a Pilot Study	Parkinson Disease	Dietary Supplement: Lactobacillus plantarum PS128	Professor Lu Neurological Clinic	NULL	Completed	40 Years	80 Years	All	30	N/A	Taiwan

97. Ulcerative colitis

---

Clinical trials : 2,527 /  Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000033953	2020-07-01	2020-06-18	Effect of the probiotic on symptoms in patients with ulcerative colitis (UC)	Effect of the probiotic on symptoms in patients with ulcerative colitis (UC)	Ulcerative colitis	Placebo group:Maltodextrin;experimental group 1:Lactobacillus plantarum CCFM8610;experimental group 2:Lactobacillus plantarum N13;experimental group 3:Lactobacillus casei CCFM1059;	Jiangnan University	NULL	Pending			Both	Placebo group:20;experimental group 1:20;experimental group 2:20;experimental group 3:20;		China

156. Rett syndrome

---

Clinical trials : 40 /  Drugs : 53 - (DrugBank : 19) / Drug target genes : 77 - Drug target pathways : 113

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03259971 (ClinicalTrials.gov)	August 25, 2017	16/8/2017	The Role of Probiotics PS128 in Movement Disorders	The Role of Probiotics PS128 in Movement Disorders	Rett Syndrome;Tourette Syndrome;Tic Disorders	Dietary Supplement: Probiotic-Lactobacillus plantarum PS128;Dietary Supplement: Placebo	National Taiwan University Hospital	NULL	Recruiting	1 Year	50 Years	All	500	N/A	Taiwan

Back to top